COVID-19: Update on Pathogenesis and Treatment Strategies

Author(s): Rakesh K. Chauhan, Pramod K. Sharma, Shikha Srivastava*

Journal Name: Current Immunology Reviews (Discontinued)

Volume 16 , Issue 1 , 2020

Graphical Abstract:


COVID-19 (Coronavirus disease) is the most contagious virus, which has been characterized as a global pandemic by WHO. The pathological cycle of COVID-19 virus can be specified as RNAaemia, severe pneumonia, along with the Ground-glass opacity (GGO), and acute cardiac injury. The S protein of Coronavirus has been reported to be involved in the entry of the virus into the host cell, which can be accomplished by direct membrane fusion between the virus and plasma membrane. In the endoplasmic reticulum or Golgi membrane, the newly formed enveloped glycoproteins are introduced. The spread of disease occurs due to contact and droplets unleashed by the vesicles holding the virus particles combined with the plasma membrane to the virus released by the host. The present manuscript describes the pathogenesis of COVID-19 and various treatment strategies that include drugs such as chloroquine and hydroxychloroquine, an anti-malarial drug, antibodies: SARS-CoV-specific human monoclonal antibody CR3022 and plasma treatment facilitate the therapeutic effect.

Keywords: COVID-19, pathogenesis, treatment, therapeutic effect, antiviral drugs, plasma therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 22 December, 2020
Page: [1 - 5]
Pages: 5
DOI: 10.2174/1573395516999201001154837
Price: $65

Article Metrics

PDF: 11